Gregory M Lanza Selected Research

gadolinium diethylene-triamine-pentaacetic acid-bis-oleate

8/2013	Molecular MR imaging of neovascular progression in the Vx2 tumor with αvβ3-targeted paramagnetic nanoparticles.
8/2003	Improved molecular imaging contrast agent for detection of human thrombus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gregory M Lanza Research Topics

Disease

39	Neoplasms (Cancer) 10/2021 - 09/2003
11	Thrombosis (Thrombus) 06/2019 - 08/2003
11	Atherosclerosis 01/2015 - 11/2003
8	Atherosclerotic Plaque (Atheroma) 01/2015 - 12/2004
7	Breast Neoplasms (Breast Cancer) 10/2021 - 08/2010
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2015 - 10/2006
7	Inflammation (Inflammations) 07/2014 - 09/2008
6	Melanoma (Melanoma, Malignant) 10/2021 - 03/2005
4	Stroke (Strokes) 09/2011 - 08/2003
3	Neoplasm Metastasis (Metastasis) 01/2021 - 09/2003
3	Pathologic Constriction (Stenosis) 04/2015 - 05/2008
3	Arthritis (Polyarthritis) 11/2012 - 09/2009
3	Rupture 02/2012 - 12/2004
3	Nephrogenic Fibrosing Dermopathy 11/2011 - 07/2008
3	Myocardial Infarction 06/2009 - 08/2003
2	Multiple Myeloma 01/2021 - 06/2015
2	Rheumatoid Arthritis 07/2014 - 11/2012
2	Hemolysis 04/2014 - 03/2014
2	Ischemia 01/2014 - 01/2004
2	Kidney Diseases (Kidney Disease) 11/2013 - 03/2011
2	Body Weight (Weight, Body) 11/2012 - 08/2010
2	Vascular System Injuries 05/2008 - 03/2004
1	Triple Negative Breast Neoplasms 01/2021
1	Venous Thrombosis (Deep-Vein Thrombosis) 06/2019
1	Pulmonary Embolism 06/2019
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2018
1	Lung Neoplasms (Lung Cancer) 01/2018
1	Brain Neoplasms (Brain Tumor) 01/2017
1	Respiratory Hypersensitivity 01/2017
1	Hypoxia (Hypoxemia) 01/2017
1	Glioma (Gliomas) 01/2017
1	Edema (Dropsy) 01/2015
1	Acute Kidney Injury (Acute Renal Failure) 06/2014
1	Muscular Dystrophies (Muscular Dystrophy) 05/2014
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 05/2014
1	Renal Insufficiency (Renal Failure) 11/2013

Drug/Important Bio-Agent (IBA)

20	FluorocarbonsIBA 01/2018 - 06/2006
17	Pharmaceutical PreparationsIBA 01/2021 - 12/2005
16	Contrast MediaIBA 01/2015 - 08/2003
14	FibrinIBA 06/2019 - 08/2003
11	IntegrinsIBA 01/2021 - 03/2005
8	Biomarkers (Surrogate Marker)IBA 01/2015 - 09/2003
7	fumagillinIBA 01/2016 - 09/2006
6	LipidsIBA 01/2018 - 12/2005
6	ProdrugsIBA 01/2017 - 11/2012
5	Lipase (Acid Lipase)FDA Link 01/2017 - 11/2012
4	RhodaminesIBA 01/2020 - 03/2011
4	Phospholipids (Phosphatides)FDA LinkGeneric 01/2018 - 01/2009
4	LigandsIBA 11/2013 - 08/2008
4	GadoliniumIBA 11/2011 - 07/2008
4	Peptides (Polypeptides)IBA 05/2011 - 09/2009
3	MicellesIBA 01/2021 - 01/2017
3	perflubron (L 1913)FDA Link 08/2015 - 06/2006
3	EpitopesIBA 01/2015 - 09/2003
3	MetalsIBA 11/2011 - 07/2008
3	CholesterolIBA 12/2008 - 11/2003
2	Docetaxel (Taxotere)FDA Link 01/2021 - 11/2017
2	Biological ProductsIBA 01/2018 - 02/2006
2	EmulsionsIBA 01/2018 - 01/2017
2	FluorineIBA 01/2015 - 09/2008
2	Sirolimus (Rapamycin)FDA Link 05/2014 - 05/2008
2	Complement System Proteins (Complement)IBA 04/2014 - 03/2014
2	Apolipoproteins E (ApoE)IBA 11/2013 - 01/2013
2	gadolinium diethylene-triamine-pentaacetic acid-bis-oleateIBA 08/2013 - 08/2003
2	Melitten (Melittin)IBA 12/2011 - 09/2009
2	Lanthanoid Series Elements (Lanthanides)IBA 11/2011 - 07/2008
2	Thromboplastin (Tissue Factor)IBA 02/2006 - 03/2004
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2021
1	Arginine (L-Arginine)FDA Link 10/2021
1	Immune Checkpoint InhibitorsIBA 10/2021
1	ArginaseIBA 10/2021
1	Melphalan (Alkeran)FDA LinkGeneric 01/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2021
1	Heparin (Liquaemin)FDA LinkGeneric 06/2019
1	Surface-Active Agents (Surfactants)IBA 01/2018
1	carbogenIBA 01/2017
1	Methacholine Chloride (Methacholine)FDA Link 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016
1	Zoledronic Acid (Zometa)FDA Link 01/2016
1	Oncogene Proteins (Oncogene Protein)IBA 06/2015
1	Environmental BiomarkersIBA 04/2015
1	AntigensIBA 01/2015
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2014
1	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2014
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2014
1	taxaneIBA 01/2014
1	gadolinium 1,4,7,10- tetraazacyclododecane- N,N',N'',N'''- tetraacetateIBA 08/2013
1	SolutionsIBA 07/2013
1	Oxygen (Dioxygen)IBA 07/2013
1	SaltsIBA 07/2013

Therapy/Procedure

27	Therapeutics 10/2021 - 09/2003
5	Drug Therapy (Chemotherapy) 01/2021 - 01/2009
4	Precision Medicine 01/2015 - 12/2009
1	Immunotherapy 10/2021
1	Neoadjuvant Therapy 01/2021
1	Secondary Prevention 01/2020
1	Liquid Ventilation 01/2018
1	Radiotherapy 01/2017
1	Injections 01/2017
1	Ligation 01/2014